Mother Delays Chemotherapy to Save Her Unborn Baby

A pregnant woman who was diagnosed of Myeloid Leukemia and had refused to take treatment rather than aborting the baby, is celebrating the birth of a healthy daughter.

A pregnant woman in the second trimester of her pregnancy, who was diagnosed of Myeloid Leukemia (blood cancer which is rare below 50years) and had refused to take treatment rather than aborting the baby, is celebrating the birth of a healthy daughter. During a routine blood test in the fifth month of pregnancy, Victoria Webster, 33, was diagnosed with cancer.

Doctors pleaded with her to have a late termination so that she could begin with a course of life-saving chemotherapy. At the same time they warned her that the medication could kill her unborn daughter. However Victoria decided to keep her baby and delay her treatment. Now the baby is 10months old and Victoria is responding well to the cancer treatment.

Acute Myeloid Leukemia-Causes-Symptoms-Diagnosis-Treatment-Prognosis-FAQs
Acute myeloid Leukemia, more popularly known by its abbreviated form AML, is a fast- evolving leukemia that affects both children and adults alike

Mrs. Webster from Birmingham, said, "My doctor told me I needed to make a choice and decide whether I should keep my baby. To me, there was no decision to make. I had already bonded with my baby while she was growing inside me and as her mum, I had to protect her. It's the best decision I have ever made. I can't imagine my life without my daughter.

Source-Medindia

Chronic Myeloid Leukemia
Chronic myeloid Leukemia is one of the most common types of blood cancer. It is characterized by excess of WBC stem cells in the bone marrow.

New Drug Combination Promises Better Treatment Outcomes in Chronic Myeloid Leukemia (CML)
Treatment with imatinib and peginterferon alfa-2a was associated with significantly higher rates of molecular responses in people with CML.

Chronic Myeloid Leukemia Needs New Treatment Strategies
The development of a drug,imatinib,that targets the protein (BCR-ABL) causing chronic myeloid leukemia (CML), had changed the cancer from a fatal to a chronic condition.